Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Industrial perspective on X-ray data collection and analysis.

Tadeusz Skarzynski1, James Thorpe

  • 1GlaxoSmithKline, UK. tadeusz.j.skarzynski@gsk.com

Acta Crystallographica. Section D, Biological Crystallography
|December 22, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Structure-based optimisation of orally active & reversible MetAP-2 inhibitors maintaining a tight 'molecular budget'.

Bioorganic & medicinal chemistry letters·2020
Same author

Characterising the role of small airways in severe asthma using low frequency forced oscillations: A combined computational and clinical approach.

Respiratory medicine·2020
Same author

Tackling burnout: why is it important?

British journal of hospital medicine (London, England : 2005)·2020
Same author

Comparison of Forced and Impulse Oscillometry Measurements: A Clinical Population and Printed Airway Model Study.

Scientific reports·2019
Same author

Collecting data in the home laboratory: evolution of X-ray sources, detectors and working practices.

Acta crystallographica. Section D, Biological crystallography·2013
Same author

Crystal structures of ASK1-inhibtor complexes provide a platform for structure-based drug design.

Protein science : a publication of the Protein Society·2013

Pharmaceutical protein crystallography uses advanced methods for drug discovery. Technology and computational approaches are key to increasing throughput and meeting medicinal chemistry project timelines for novel drug targets.

Area of Science:

  • Structural biology
  • Drug discovery
  • Medicinal chemistry

Background:

  • Pharmaceutical industry research teams utilize protein crystallography, similar to academic groups, but with distinct approaches for drug discovery.
  • The focus is on determining novel structures of drug targets and their complexes with potential drug candidates.

Purpose of the Study:

  • To provide an overview of current X-ray data collection and processing approaches in the industrial pharmaceutical environment.
  • To highlight how technology addresses the challenges of high-throughput structural biology in drug development.

Main Methods:

  • X-ray data collection strategies in an industrial setting.
  • Computational methods for accelerating structure determination.
  • High-throughput screening and analysis of protein crystal structures.

Related Experiment Videos

Main Results:

  • Industrial protein crystallography prioritizes timely delivery of crystal structures relevant to medicinal chemistry.
  • Technological advancements and computational methods are crucial for increasing efficiency and throughput.
  • Examples demonstrate the application of technology to overcome high-throughput challenges.

Conclusions:

  • Industrial structural biology employs distinct practices to meet the rapid demands of drug discovery.
  • Investment in technology and computational methods is vital for high-throughput structure determination.
  • Optimized workflows are essential for impacting medicinal chemistry projects efficiently.